Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Acq. announced
Inv. presentation
|
|
Mirum Pharmaceuticals, Inc. (MIRM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/14/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/01/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/18/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/16/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/02/2022 |
SC 13D/A
| Novo Holdings A/S reports a 5.9% stake in Mirum Pharmaceuticals, Inc. |
| 04/08/2022 |
SC 13D/A
| Novo Holdings A/S reports a 6.9% stake in Mirum Pharmaceuticals, Inc. |
| 08/24/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/22/2020 |
SC 13D/A
| RiverVest Venture Fund IV, L.P. reports a 6.6% stake in MIRUM PHARMACEUTICALS, INC. |
| 12/18/2020 |
SC 13D/A
| Novo Holdings A/S reports a 8.4% stake in Mirum Pharmaceuticals, Inc. |
| 12/18/2020 |
SC 13D/A
| Frazier Life Sciences IX, L.P. reports a 12.2% stake in Mirum Pharmaceuticals, Inc. |
| 04/29/2020 |
SC 13D/A
| Frazier Life Sciences IX, L.P. reports a 14% stake in Mirum Pharmaceuticals, Inc. |
| 01/17/2020 |
SC 13D/A
| Novo A/S reports a 9.6% stake in Mirum Pharmaceuticals, Inc. |
|
|